Phillip T. and Susan M. Ragon Foundation Report issue

Foundation Phase 1

Organization Overview

First Clinical Trial
2010
NCT01123915
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

opal-hiv-gag(c) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 1)

Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1